Tianjin Hospital
11
2
2
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
9%
1 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy
Role: collaborator
Infrapatellar Fat Pad Preservation Versus Resection on Clinical Outcomes After Total Knee Arthroplasty(IPAKA)
Role: collaborator
Oral Prednisone in Treating LCH of Bone in Childhood and Adolescence
Role: collaborator
Enhanced Recovery After Surgery (ERAS) in Patients Undergoing Emergency Laparotomy
Role: collaborator
En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor.
Role: collaborator
Degenerative Lumbar Scoliosis
Role: collaborator
A Prospective Multicenter Cohort Study About Internal Fixation Using FNS Versus MCS for Femoral Neck Fracture
Role: collaborator
Deep Learning of Knee Joint MRI Intelligent Detection
Role: collaborator
Treatment of Cartilage Defects With Peripheral Blood Stem Cells
Role: collaborator
Effect of Feedback Health Education on Postoperative Rehabilitation of Patients With Lumbar Disc Herniation
Role: lead
Clinical Trial for the Application of Tirobot System
Role: collaborator
All 11 trials loaded